LY518674
LY518674 is a potent and selective PPARα agonist (EC50 = 42 nM for human PPARα) used in atherosclerosis research. It modulates lipid metabolism by lowering triglycerides and raising HDL-C, making it a valuable tool for in vitro and in vivo studies of cardiovascular disease and metabolic disorders.
Product Specifications
CAS Number
425671-29-0
Product Name Alternative
Atherosclerosis, human PPARα, LY674, LY-674, LY-518674, LY518674, LY 518674, LY 674, Inhibitor, inhibit, Peroxisome proliferator-activated receptors, PPAR, PPARα
Field of Research
Metabolism Research, Molecular Biology
Purity
98.87% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (12.21 mM) ; DMSO:250 mg/mL (610.53 mM)
Smiles
Cc1ccc (Cn2[nH]c (CCCc3ccc (OC (C) (C) C (O) =O) cc3) nc2=O) cc1
Molecular Formula
C23H27N3O4
Molecular Weight
409.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog